Paul OConnell - Vascular Solutions Insider

VASC -- USA Stock  

USD 56.00  0.00  0.00%

Mr. Paul OConnell is an Independent Director of Vascular Solutions, Inc., since January 29, 2002. He In January of 2014, Mr. OConnell became President of B. Braun CeGat, a genomic sequencing and diagnostic company providing services to clinicians and hospitals in the United States. Since 2001, Mr. OConnell has also been serving as President of B. Braun Interventional Systems, Inc., a wholly owned subsidiary of B. Braun Melsungen AG, a global supplier of products for anesthesia, intensive medicine, cardiology, extra corporeal blood treatment and surgery as well as services for hospitals, general practitioners and the homecare sector. Mr. OConnell was previously Vice President of the Vascular Interventional Products Group of B. Braun Medical, an international medical device company, from 1989 to 2001. In addition, from 1999 through 2001, Mr. OConnell provided marketing and technical support consulting services to medical device companies. Mr. OConnell was the owner of Sablier, a medical device company, from 1998 through 1999 where he developed new technologies for the treatment of thromboembolic diseases and for distal protection during carotid endarterectomy. From 1993 through 1998, Mr. OConnell was Vice President and General Manager of the Vena Tech division of B. Braun Medical, a medical device business he originally cofounded in 1988 and sold to B. Braun Medical in 1993. Through more than 20 years of experience as the General Manager or President of growthoriented medical device companies within cardiology and radiology fields of practice,
Age: 61  Director Since 2002      
877 656-4251

Paul OConnell Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 6.28 % which means that it generated profit of $6.28 on every $100 spent on asset. This is normal as compared to the sector avarege.
The company currently holds 867 K in liabilities with Debt to Equity (D/E) ratio of 0.13 which may suggest the company is not taking enough advantage from borrowing. Vascular Solutions has Current Ratio of 6.24 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Entity Summary

Vascular Solutions, Inc., a medical device company, offer clinical solutions for treating coronary and peripheral vascular disease worldwide. Vascular Solutions (VASC) is traded on NASDAQ in USA. It is located in 6464 Sycamore Court North, Minneapolis, MN 55369, United States and employs 568 people.

Vascular Solutions Leadership Team

John Erb, Independent Chairman of the Board
Brett Demchuk, Vice President - Product Quality
Phillip Nalbone, Vice President - Corporate Development
Brent Binkowski, Sr. VP of Operations
William Rutstein, Sr. VP of International Sales
Richard Kramp, Independent Director
Jorge Saucedo, Independent Director
Jonathan Hammond, Vice President - Manufacturing Engineering
Charmaine Sutton, Sr. VP of Operations
Chad Kugler, Sr. VP of RandD
Martin Emerson, Independent Director
Richard Nigon, Independent Director
James Hennen, CFO and Sr. VP of Fin.
Susan Christian, Vice President - Sales Operations
Paul OConnell, Independent Director
Carrie Powers, VP of Marketing
Howard Root, Co-Founder, CEO and Director

Stock Performance Indicators

Did you try this?

Run Correlation Analysis Now

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
All  Next Launch Correlation Analysis

Also Currentnly Active

Purchased over 20 shares of
few hours ago
Traded for 106.27
Purchased over 200 shares of
few hours ago
Traded for 10.56
Purchased over 70 shares of
few hours ago
Traded for 39.4
Also please take a look at World Market Map. Please also try CEO Directory module to screen ceos from public companies around the world.